Advanced Health Intelligence Ltd secures $2.27 million R&D Reimbursement Under Australia's R&D Tax Incentive Scheme
Advanced Health Intelligence Ltd (ASX/NASDAQ: AHI) (“AHI” or the “Company”) is pleased to inform shareholders that the company will receive $2,278,757 from the Australian Tax Office under the Australian Government Research and Development Tax Incentive Scheme (R&DTI).